logo
Bharat Forecast System: India launches world's most precise weather model to improve predictions

Bharat Forecast System: India launches world's most precise weather model to improve predictions

Time of India26-05-2025
PTI photo
NEW DELHI: In a major boost to India's weather prediction capabilities, the government on Monday unveiled the Bharat Forecasting System (BFS) — the world's highest-resolution weather model, operating on a 6-kilometre grid.
Developed by researchers including Parthasarathy Mukhopadhyay, the model aims to deliver more granular and accurate forecasts, especially for small-scale weather patterns.
"This significant milestone represents a major leap in India's self-reliance in meteorological sciences, enabling more accurate and granular weather forecasts up to panchayat level for disaster risk reduction, agriculture, water resource management and public safety," a senior official from the Earth Sciences Ministry said.
The BFS was made possible through the installation of Arka, a new supercomputer at the Indian Institute of Tropical Meteorology (IITM) campus last year. Arka boasts a computational capacity of 11.77 petaflops and a storage capacity of 33 petabytes.
"The previous supercomputer 'Pratyush' used to take up to 10 hours to run the forecasting model. Arka performs the same data-crunching within four hours," Mukhopadhyay told news agency PTI.
Union Earth Sciences Minister Jitendra Singh dedicated the Bharat Forecasting System to the nation at a function in New Delhi.
According to M. Ravichandran, the BFS will leverage a network of 40 Doppler Weather Radars from across India to generate highly localised forecasts.
'The BFS provides insight into weather events likely to take place in a grid of 6 km by 6 km against the earlier models that gave predictions for a 12 km grid,' he explained.
The number of Doppler radars is expected to rise to 100, which would allow the weather office to issue nowcasts — short-term forecasts for the next two hours — for the entire country.
The system offers high-resolution forecasts for the tropical region between 30 degrees South and 30 degrees North latitudes, which includes the Indian mainland spanning from 8.4 degrees to 37.6 degrees North. In comparison, Ravichandran pointed out that the global forecast models run by the European, British, and US weather offices operate at resolutions ranging from 9 km to 14 km.
The BFS arrives at a critical time when weather anomalies are increasingly influencing India's economy, particularly in the form of sticky food inflation. The government, in its latest Economic Survey, noted that frequent extreme weather events over the past two years have played a significant role in driving up food prices.
Data from the Centre for Science and Environment (CSE) cited in the report highlighted that the total crop area damaged in 2024 due to extreme weather was higher than in previous years.
India Meteorological Department
(IMD) data, according to the Economic Times, revealed a notable increase in the frequency of such events. Between 2022 and 2024, heatwaves were recorded on 18 per cent of days, a sharp rise from 5 per cent during 2020 and 2021.
The Economic Survey recommended developing climate-resilient crops, improving data systems, and reducing both crop damage and post-harvest losses to achieve long-term price stability.
Supporting these concerns, the Reserve Bank of India (RBI) in its monthly bulletin flagged the impact of weather anomalies on vegetable prices, stating that temperature anomalies have increased, prompting the need for temperature-resistant crop varieties.
Despite these concerns, the bulletin noted that the inflation outlook has improved, with food inflation declining more than expected. However, weather-related and global risks continue to pose challenges.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Moderate earthquake hits eastern Nepal district
Moderate earthquake hits eastern Nepal district

News18

time13 minutes ago

  • News18

Moderate earthquake hits eastern Nepal district

Agency: PTI Last Updated: Kathmandu, Aug 17 (PTI) An earthquake measuring magnitude 4.0 struck Ramechhap district of eastern Nepal on Sunday. However, there was no immediate report of any damage caused by the earthquake. The epicentre of the quake that occurred at 3.43 pm local time was located at Helamcho area in Ramechhap, 150 kms east of Kathmandu, according to National Earthquake Monitoring and Research Centre (NEMRC). The earthquake was also felt in neighbouring Dolakha, Sindhuli and Kavrepalanchowk districts. Situated on the precarious Himalayan seismic zone, Nepal is a highly earthquake prone country. PTI SBP NPK NPK view comments First Published: Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.

Heavy rains lash parts of Delhi; minimum temperature at 25.6 degrees
Heavy rains lash parts of Delhi; minimum temperature at 25.6 degrees

News18

time3 hours ago

  • News18

Heavy rains lash parts of Delhi; minimum temperature at 25.6 degrees

Agency: New Delhi, Aug 17 (PTI) Rains lashed different parts of the national capital on Sunday afternoon. Areas such as Dhaula Kuan, Naraina, Patel Nagar, Vijay Chowk, Jangpura, Rohini, Firozshah Road and Parliament Street received rainfall, the India Meteorological Department (IMD) said. According to the IMD, the city recorded 1 mm rain in the 24 hours ending 8.30 am on Sunday. Earlier in the day, the weather department had forecast generally cloudy sky with one or two spells of rain or thundershowers, with the maximum temperature expected to settle around 33 degrees Celsius. Meanwhile, the city recorded a minimum temperature of 25.6 degrees Celsius, 0.9 notches below the season's average. Relative humidity was recorded at 90 per cent at 8.30 am. The air quality remained in the 'satisfactory' category at 4 pm, with an Air Quality Index (AQI) reading of 91, the Central Pollution Control Board (CPCB) data showed. According to the CPCB, an AQI between zero and 50 is considered 'good', 51 to 100 'satisfactory', 101 to 200 'moderate', 201 to 300 'poor', 301 to 400 'very poor', and 401 to 500 'severe'. PTI SHB RUK RUK (This story has not been edited by News18 staff and is published from a syndicated news agency feed - PTI) view comments First Published: August 17, 2025, 18:45 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.

Smoking status must be captured in cancer trials, experts say in new study
Smoking status must be captured in cancer trials, experts say in new study

News18

time4 hours ago

  • News18

Smoking status must be captured in cancer trials, experts say in new study

New Delhi, Aug 17 (PTI) A group of experts from AIIMS Delhi, McMaster University in Canada and the International Agency for Research on Cancer (IARC) in France has stressed the need to record smoking status in cancer clinical trials, warning that continued tobacco use can reduce treatment efficacy and patient survival. In a commentary published in the Lancet Oncology this month, the seven authors, including Dr Abhishek Shankar from AIIMS Delhi, said knowledge of smoking status during therapy could influence clinical decisions. They argued that addressing barriers to tobacco-use assessment and embedding smoking cessation initiatives into oncology research protocols will improve trial outcomes, enhance therapeutic efficacy and save lives. The researchers cited the 2014 US Surgeon General's report 'The Health Consequences of Smoking — 50 Years of Progress', which for the first time concluded there was a causal link between cigarette smoking and adverse cancer-related outcomes, including higher all-cause and cancer-specific mortality. This report underscores the need to systematically capture smoking status in clinical trials, to refine estimates of efficacy of novel therapies and to better understand the impact of continued tobacco use across treatment modalities and disease sites. Since 2014, research has increasingly shown that continued tobacco use negatively impacts patients receiving surgery, radiotherapy or systemic therapies. The mechanisms by which tobacco smoke worsens outcomes remain unclear but may include tumour hypoxia, altered drug metabolism, stimulation of signalling pathways by nicotine and changes to the immune system, including reduced natural killer cells, the authors noted. 'Little is known about how best to overcome the effects of tobacco smoke, apart from cessation of tobacco use. Knowledge of smoking status during cancer therapy could potentially influence clinical decisions," the authors said in the commentary. They cited how the dose of erlotinib has to be doubled (from 150 mg to 300 mg daily) to achieve therapeutic concentrations in patients who continue smoking. 'These findings highlight a large gap in our understanding of how continued tobacco use might influence drug metabolism, therapeutic response and long-term outcomes," the experts said, adding that the issue is most pressing in low and middle-income countries with 80 per cent of tobacco users. Meta-analyses of lung, head and neck, hormone-responsive and other cancers show that quitting smoking after diagnosis results in longer survival, with early quitting offering the greatest benefits. The authors stressed that the survival advantage of quitting could even exceed the impact of the therapy under investigation. They also cautioned that failure to collect smoking data risks confounding trial results, especially if treatment groups are unbalanced for tobacco use. The commentary pointed out that the 2020 US Surgeon General's report recommended structured cessation efforts as standard cancer care, though it said more data was needed to confirm a causal link with improved survival. The authors referred to a 2020 US FDA–AACR–IASLC workshop which addressed the importance of tobacco-use assessment in oncology trials. Despite such efforts and published evidence, clinical trials still rarely incorporate robust tobacco-use assessments, they said. Absence of standardised tools and protocols for assessing tobacco use leads to inconsistencies in data collection, making it challenging to compare results across studies, authors added. They further said that some researchers and clinicians might perceive tobacco use as having minimal impact on clinical outcomes, leading to its omission from data collection. 'However, evidence strongly suggests that continued tobacco use can have a substantial adverse effect on cancer treatment efficacy and patient survival," the authors said. They also said that opportunities to intervene with current users after diagnosis have been missed, and more research is needed on mechanisms by which tobacco worsens outcomes. Collecting detailed smoking data requires time and resources, which might be limited in clinical trial settings, they pointed out. Electronic health record systems might not have integrated templates for recording smoking status information, leading to inconsistent documentation. The absence of automated prompts or referral systems can further impede the collection of accurate tobacco use data, the doctors said, adding that pharmaceutical manufacturers might perceive smoking status assessments as a threat. If smoking diminishes a drug's efficacy or exacerbates side-effects, it could negatively impact regulatory approval and market size, they added. Referring to a 2024 study by Cincirpini and colleagues, they said cessation support should ideally be provided within six months of diagnosis to observe the greatest survival benefit. With e-cigarette use rising globally, their use should also be captured in trials, though their impact is likely to be less severe than active smoking. In the past decade, many cancer centres in Canada, Australia and the US have made smoking cessation discussions standard practice at the time of patient registration, with advice and referrals offered. In 2023, the IASLC's Tobacco Control and Smoking Cessation Committee also issued a position statement declaring smoking status capture as a key standard for clinical trial design. 'Capturing smoking status in clinical trials should no longer be considered optional; it should be regarded as an essential core element of cancer research," the authors concluded. PTI PLB OZ OZ (This story has not been edited by News18 staff and is published from a syndicated news agency feed - PTI) view comments First Published: August 17, 2025, 18:00 IST News agency-feeds Smoking status must be captured in cancer trials, experts say in new study Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store